Holen Sie sich die Stockscreener-App
57.64
0.24%
-0.14
Handel nachbörslich:
57.92
0.28
+0.49%
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Boston Scientific Bets on WATCHMAN to Drive Structural Heart Growth - Yahoo Finance
Boston Scientific Corp. stock (US10117L1017): Q1 beat and raised guidance keep medtech on investors - AD HOC NEWS
BofA Cuts PT on Boston Scientific Corporation (BSX) Over Worries for Medtech - Yahoo Finance
Boston Scientific Corp. stock (US10117L1017): Pipeline momentum and earnings keep medtech investor i - AD HOC NEWS
Boston Scientific (BSX) Invests $1.5B in MiRus for Significant E - GuruFocus
BSX Stock Quote Price and Forecast - CNN
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific’s SWOT analysis: stock navigates strategic expansion - Investing.com
Why Is Boston Scientific (BSX) Down 13% Since Last Earnings Report? - Yahoo Finance
Rx Rundown: Parabilis Medicines, Boston Scientific, Amgen and more - Medical Marketing and Media
Insider Buying: Cheryl Pegus Acquires Shares of Boston Scientifi - GuruFocus
Boston Scientific director Cheryl Pegus buys $99,987 in stock - Investing.com UK
Boston Scientific director Ludwig buys $202,914 in stock By Investing.com - Investing.com Australia
Boston Scientific director Ludwig buys $202,914 in stock - Investing.com
Director Cheryl Pegus buys Boston Scientific (BSX) shares in open-market trade - Stock Titan
Director Edward J. Ludwig buys 3,580 Boston Scientific (BSX) shares in open market - Stock Titan
Boston Scientific (NYSE: BSX) director adds 4,450 company shares - Stock Titan
Boston Scientific Corp (NYSE:BSX) GARP Growth at a Reasonable Price Meets Strong Fundamentals - ChartMill
Boston Scientific’s strategic investment in MiRus includes option to acquire TAVR system - Today's Medical Developments
Mengis Capital Management, Inc.'s Boston Scientific Corp(BSX) Holding History - GuruFocus
Subgroup analysis of the Champion-AF trial shows age not a factor - BioWorld News
Boston Scientific stock (US10117L1017): Q1 sales rise as Wall Street tracks procedure demand - AD HOC NEWS
Boston Scientific Corporation (BSX) Fell Due to Weak Results - Yahoo Finance
Baird Maintains Bullish View on Boston Scientific (BSX) Despite Lower Target - Insider Monkey
ODDO BHF ASSET MANAGEMENT SAS's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific Corp. stock (US10117L1017): market eyes next catalysts after recent updates - AD HOC NEWS
OXFORD ASSET MANAGEMENT LLP's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific (BSX) Achieves Positive Results in CAD Treatme - GuruFocus
Boston Scientific Advances Coronary Calcium Treatment With Positive Trial Results - Benzinga
Boston Scientific reports Seismiq IVL data from Fracture study - BioWorld News
Boston Scientific’s coronary IVL catheter hits primary endpoints in trial - Yahoo Finance
Boston Scientific stock rating reiterated at Buy by TD Cowen - Investing.com
Piper Sandler reiterates Boston Scientific stock rating on device outlook - Investing.com
Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy? - Yahoo Finance
Boston Scientific coronary device meets trial endpoints - Investing.com
Boston Scientific posts positive data for coronary IVL catheter - Yahoo Finance
FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints - Morningstar
Boston Scientific invests $1.5bn for equity stake in MiRus - Yahoo Finance
Boston Scientific Corp (BSX) Stock Up 6.2% and Still Undervalued -- GF Score: 83/100 - GuruFocus
Boston Scientific stock (US10117L1017): New catalyst watch after recent company developments - AD HOC NEWS
Boston Scientific Pairs US$2b Buyback With MiRus TAVR Growth Bet - Yahoo Finance
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years - Benzinga
Joel Greenblatt's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific (BSX) Announces $2 Billion Accelerated Share R - GuruFocus
Boston Scientific Corp Stock (BSX) Closed Up by 5.88% on May 18: Facts Behind the Movement - TradingKey
Boston Scientific invests $1.5B in MiRus heart valve startup - Yahoo Finance
Boston Scientific Targets Growing Aortic Stenosis Market With $1.5 Billion Deal - Benzinga
BSX Reiterated by Needham -- Price Target Maintained at $77.00 - GuruFocus
Boston Scientific Bets on Growth Through Strategic M&A Deals - Yahoo Finance
Boston Scientific (BSX) Invests $1.5B in MiRus for 34% Equity St - GuruFocus
Boston Scientific returns to heart-valve market with $1.5B investment in startup - The Business Journals
Boston Scientific Invests $1.5 Billion in MiRus for Exclusive Option on Innovative Nickel-Free Balloon Expandable TAVR Valve - Minichart
Boston Scientific Announces $2 Billion Accelerated Share Repurchase Agreement to Boost Shareholder Value - Minichart
Truist reiterates Boston Scientific stock rating on MiRus deal - Investing.com
Boston Scientific (BSX) Invests $1.5B in MiRus for Cardiovascula - GuruFocus
Why is Boston Scientific stock rallying today? - Investing.com
Boston Sci invests $1.5B in Mirus, gains option for TAVR system - BioWorld News
Boston Scientific shares rise after $1.5B MiRus investment and $2B accelerated buyback - Quiver Quantitative
Boston Scientific shares rise after $2 billion buyback and MiRus investment (BSX) - MSN
Boston Scientific (BSX) Announces $2 Billion Accelerated Share Repurchase Agreement - GuruFocus
Boston Scientific Shares Rise After $2 Billion Buyback and MiRus Investment (BSX) - Yahoo Finance
Boston Scientific Stock Surges As Traders Embrace Reset - StocksToTrade
Boston Scientific stock gains on $2B share buyback plan - Investing.com
Here’s Why Boston Scientific’s Stock (BSX) Is Surging Today - TipRanks
Boston Scientific buys 34% stake in MiRus for $1.5bn - Sharecast.com
Boston Scientific enters $2B share buyback agreement - Investing.com
1.27%
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):